15-71111241-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NR_168259.1(CT62):n.838C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000716 in 1,613,882 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00055 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00073 ( 1 hom. )
Consequence
CT62
NR_168259.1 non_coding_transcript_exon
NR_168259.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.397
Genes affected
CT62 (HGNC:27286): (cancer/testis associated 62)
THSD4 (HGNC:25835): (thrombospondin type 1 domain containing 4) Predicted to enable hydrolase activity. Predicted to be an extracellular matrix structural constituent. Predicted to act upstream of or within elastic fiber assembly. Located in collagen-containing extracellular matrix and extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 15-71111241-G-A is Benign according to our data. Variant chr15-71111241-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2645497.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CT62 | NR_168259.1 | n.838C>T | non_coding_transcript_exon_variant | 4/4 | |||
THSD4 | NM_001394532.1 | c.-80+14235G>A | intron_variant | ||||
CT62 | NR_168260.1 | n.1047C>T | non_coding_transcript_exon_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CT62 | ENST00000648023.1 | n.828C>T | non_coding_transcript_exon_variant | 4/4 |
Frequencies
GnomAD3 genomes AF: 0.000552 AC: 84AN: 152182Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
84
AN:
152182
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000843 AC: 210AN: 249200Hom.: 0 AF XY: 0.000851 AC XY: 115AN XY: 135186
GnomAD3 exomes
AF:
AC:
210
AN:
249200
Hom.:
AF XY:
AC XY:
115
AN XY:
135186
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000733 AC: 1071AN: 1461582Hom.: 1 Cov.: 32 AF XY: 0.000740 AC XY: 538AN XY: 727088
GnomAD4 exome
AF:
AC:
1071
AN:
1461582
Hom.:
Cov.:
32
AF XY:
AC XY:
538
AN XY:
727088
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000552 AC: 84AN: 152300Hom.: 1 Cov.: 33 AF XY: 0.000564 AC XY: 42AN XY: 74490
GnomAD4 genome
AF:
AC:
84
AN:
152300
Hom.:
Cov.:
33
AF XY:
AC XY:
42
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | CT62: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at